The integration will enable Leica’s BOND staining systems to simultaneously detect RNA and protein targets on the same tissue ...
LOS ANGELES--(BUSINESS WIRE)--Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Molecular Instruments® (MI), the inventor of the HCR™ Imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results